GlassScriptPhysician profile
Steven Earl Park
NPI 1457385817
$8,267.04
in general payments reported to CMS, 2019-2025
25 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,643 · 2020: $787 · 2021: $1,470 · 2022: $2,387 · 2023: $1,074 · 2024: $739 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,921 · Travel and Lodging: $59.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,920.88 |
| Travel and Lodging | $59.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $2,655.15 | 2019-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Atricure, INC. | $2,065.31 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Artivion, INC. | $1,837.45 | 2019-2025 | Cardiac Non-Synergraft, Cryovalve Sg Pulmonary Human Heart Valve, Amds-Ascyrus Medical |
| Medtronic, INC. | $396.67 | 2021-2024 | Mosaic, Freestyle, Signia |
| Medtronic Vascular, INC. | $285.98 | 2019-2020 | |
| Haemonetics Corporation | $176.71 | 2023 | Teg6s Hemostasis System |
| Covidien LP | $135.44 | 2019 | |
| Zimmer Biomet Holdings, INC. | $102.46 | 2021 | |
| Angiodynamics, INC. | $100.50 | 2021 | |
| Lemaitre Vascular, INC. | $90.48 | 2024 | Artegraft Vascular Graft |
| Janssen Pharmaceuticals, INC | $71.95 | 2022-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $55.66 | 2022-2023 | |
| Corcym INC | $45.68 | 2022 | |
| Lsi Solutions INC | $44.10 | 2021-2023 | Cor Knot |
| Abiomed | $25.50 | 2024 | Impella |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hemosonics LLC | $23.54 | 2023 | Quantra Qplus System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.69 | 2025 | Jardiance |
| Abbott Laboratories | $19.61 | 2022 | |
| Alnylam Pharmaceuticals INC. | $19.03 | 2022 | |
| Baxter Healthcare | $17.64 | 2022 | |
| Novo Nordisk INC | $16.26 | 2021 | |
| Astellas Pharma US INC | $15.82 | 2021 | |
| Ethicon US, LLC | $15.28 | 2025 | Vistaseal, Dermabond |
| Pfizer INC. | $14.78 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $14.35 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.